Surgery or Surveillance? AI May Help Decide

Study published in Gut evaluated CompCyst-AI for pancreatic cancer detection.

It analyzes cyst fluid samples combining genomic, proteomic, and clinical data.

Study involved 862 patients undergoing cyst resection.

CompCyst-AI matched pathology management in 72 percent of cases.

Identified 90 percent of patients with high-grade dysplasia requiring surgery.

Reduced unnecessary surgeries for low-risk patients.

Future studies needed for non-operatively managed patients.